Building Investor Confidence in Microbiome Drug Development; How to Promote & Restore Confidence

Time: 1:00 pm
day: Day Two – Track C – 1


  • Numerous challenges from bench to bedside but overall industry progress
  • Selecting therapeutically-relevant indications beyond C. difficile
  • The impact of recent clinical setbacks – lessons learned on how and when to enter clinic with microbiome therapeutics